Addition of nebulised lidocaine to prevent refractory bronchospasms in a patient receiving serial bronchoscopies

Ryan Grell*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

A patient in his 20s with a history of granulomatosis with polyangiitis required 15 bronchoscopies with dilations in 1 year due to bronchial fibrosis and secretions leading to worsening shortness of breath. During these bronchoscopies, the patient experienced increasingly severe bronchospasms refractory to conventional preventative and treatment methodologies leading to prolonged hypoxia, reintubations and ICU admissions. During his 8th to 15th bronchoscopies, nebulised lidocaine was added to the pretreatment regimen, which eliminated perioperative bronchospasms and allowed for the elimination of all other adjunctive preventative treatments. This case highlights the novel perioperative use of nebulised lidocaine, in combination with nebulised albuterol and intravenous hydrocortisone, to successfully prevent previously refractory bronchospasms in a patient undergoing a general anaesthetic.

Original languageEnglish (US)
Article numbere253592
JournalBMJ case reports
Volume16
Issue number2
DOIs
StatePublished - Feb 21 2023

Keywords

  • Adult intensive care
  • Anaesthesia
  • Drugs: respiratory system
  • Perioperative care
  • Respiratory system

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Addition of nebulised lidocaine to prevent refractory bronchospasms in a patient receiving serial bronchoscopies'. Together they form a unique fingerprint.

Cite this